These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2949253)

  • 41. Immune response to vaccination against Argentine hemorrhagic Fever in an area where different arenaviruses coexist.
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sabattini MS
    Viral Immunol; 2006; 19(2):196-201. PubMed ID: 16817762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapy of Argentinian hemorrhagic fever].
    Weissenbacher MC
    Medicina (B Aires); 1985; 45(6):694-6. PubMed ID: 3842474
    [No Abstract]   [Full Text] [Related]  

  • 43. From the Centers for Disease Control and Prevention. Bolivian hemorrhagic fever--El Beni Department, Bolivia, 1994.
    JAMA; 1995 Jan; 273(3):194-6. PubMed ID: 7807656
    [No Abstract]   [Full Text] [Related]  

  • 44. Junin virus replication in peripheral blood mononuclear cells of patients with Argentine haemorrhagic fever.
    Ambrosio M; Vallejos A; Saavedra C; Maiztegui JI
    Acta Virol; 1990 Feb; 34(1):58-63. PubMed ID: 1975726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro inactivation of complement by a serum factor present in Junin-virus infected guinea-pigs.
    Rimoldi MT; de Bracco MM
    Immunology; 1980 Feb; 39(2):159-64. PubMed ID: 6247264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The glycoprotein precursor gene of Junin virus determines the virulence of the Romero strain and the attenuation of the Candid #1 strain in a representative animal model of Argentine hemorrhagic fever.
    Seregin AV; Yun NE; Miller M; Aronson J; Smith JK; Walker AG; Smith JN; Huang C; Manning JT; de la Torre JC; Paessler S
    J Virol; 2015 Jun; 89(11):5949-56. PubMed ID: 25810546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further studies on the plasma inhibitor of platelet activation in Argentine hemorrhagic fever.
    Marta RF; Heller MV; Maiztegui JI; Molinas FC
    Thromb Haemost; 1993 May; 69(5):526-7. PubMed ID: 8322277
    [No Abstract]   [Full Text] [Related]  

  • 48. [Modification of the course of Junin virus infection in guinea pigs by administration of immune sera].
    Laguens RM; Calello MA; Weissenbacher MC; Laguens RP
    Medicina (B Aires); 1985; 45(6):621-6. PubMed ID: 3023791
    [No Abstract]   [Full Text] [Related]  

  • 49. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Junín virus. A XXI century update.
    Gómez RM; Jaquenod de Giusti C; Sanchez Vallduvi MM; Frik J; Ferrer MF; Schattner M
    Microbes Infect; 2011 Apr; 13(4):303-11. PubMed ID: 21238601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hemorrhagic fever and the dengue shock syndrome].
    Ramos C; García H; Villaseca JM
    Salud Publica Mex; 1993; 35(1):39-55. PubMed ID: 8470020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemorrhagic fever in Argentina. Epidemiology. Its occurrence in childhood].
    Sujoy E; Pizzia A; Ostrovsky M
    Arch Argent Pediatr; 1965; 63(11):435-42. PubMed ID: 5877186
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prevalence of subclinical Junin virus infection in a select population of an endemic area of argentinian hemorrhagic fever].
    de Guerrero LB; Avila MM; Milani HL; Ruggiero H; Weissenbacher MC
    Medicina (B Aires); 1982; 42(1):110. PubMed ID: 7132697
    [No Abstract]   [Full Text] [Related]  

  • 54. Suspected Crimean Congo Haemorrhagic Fever cases in Albania.
    Papa A; Bino S; Papadimitriou E; Velo E; Dhimolea M; Antoniadis A
    Scand J Infect Dis; 2008; 40(11-12):978-80. PubMed ID: 18609200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of cell fusion in Junin virus-infected cells by sera from Argentine hemorrhagic fever patients.
    Castilla V; Contigiani M; Mersich SE
    J Clin Virol; 2005 Apr; 32(4):286-8. PubMed ID: 15780806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New findings on Junin virus infection in rodents inside and outside the endemic area of hemorrhagic fever in Argentina].
    Mills JN; Calderón GE; Ellis BA; McKee KT; Ksiazek TG; Oro JG; Peters CJ; Childs JE; Maiztegui JI
    Medicina (B Aires); 1991; 51(6):519-23. PubMed ID: 7476104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [ARGENTINIAN HEMORRHAGIC FEVER. IV. CLINICAL FORMS].
    RUGIERO HR; CINTORA FA; MAGNONI C; RUGGIERO H; GONZALEZCAMBACERES C; MAGLIO F; ASTARLOA L; SQUASSI G; GIACOSA A; FERNANDEZ D
    Rev Asoc Med Argent; 1964 Sep; 78():500-10. PubMed ID: 14223329
    [No Abstract]   [Full Text] [Related]  

  • 58. Quali-quantitative study of the social variables defining transmission scenarios of Argentine Hemorrhagic Fever in the provinces of Buenos Aires and Santa Fe, 2001-2010.
    Mastrangelo A; Tagliabue P; Berro L; De Carolis D; Sinchi A; Digilio C; Enria D
    Salud Colect; 2014 Aug; 10(2):171-84. PubMed ID: 25237798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome.
    Maiztegui JI; Fernandez NJ; de Damilano AJ
    Lancet; 1979 Dec; 2(8154):1216-7. PubMed ID: 92624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of highly virulent mammarenavirus infections-status quo and future directions.
    Nuñez IA; Crane A; Crozier I; Worwa G; Kuhn JH
    Expert Opin Drug Discov; 2024 May; 19(5):537-551. PubMed ID: 38606475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.